BNP Paribas Financial Markets’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.6K | Buy |
1,558
+828
| +113% | +$1.91K | ﹤0.01% | 4176 |
|
|
2025
Q1 | $5.7K | Sell |
730
-24,783
| -97% | -$194K | ﹤0.01% | 3992 |
|
|
2024
Q4 | $119K | Buy |
25,513
+22,678
| +800% | +$106K | ﹤0.01% | 3258 |
|
|
2024
Q3 | $15.3K | Buy |
2,835
+1,956
| +223% | +$10.5K | ﹤0.01% | 3042 |
|
|
2024
Q2 | $7.75K | Buy |
+879
| New | +$7.75K | ﹤0.01% | 3068 |
|
|
2022
Q4 | – | Sell |
-371
| Closed | -$2.3K | – | 3617 |
|
|
2022
Q3 | $2.3K | Buy |
+371
| New | +$2.3K | ﹤0.01% | 3617 |
|